Jump to Navigation



Today there’s more opportunity for doctors to
counsel better, forecast better, plan better.

Accuracy. It's in our DNA.

Introducing FoundationACT, our best-in-class,
reliable blood-based circulating tumor DNA assay

Learn More

FoundationOne Heme publishes
analytic validation and clinical

experience in Blood

Did you know

that more than 30% NSCLC patients with ALK fusions may have tested negatively for ALK by FISH*?

Learn more about the importance of comprehensive genomic profiling in lung cancer.

Every Cancer is Unique

Learn more about how FoundationOne can
help tailor your treatment options.

What is FoundationOne®?

FoundationOne®, FoundationOne® Heme, and FoundationACT™ are fully informative genomic profiles that help physicians make treatment decisions for patients with cancer. Our assays  identify the molecular growth drivers of a patient's cancer and help oncologists match them with relevant targeted therapies and immunotherapies.

Watch Now
Cancer and Treatment Options

Discover more about cancer and learn about available treatment options.

Watch Now


Featured Publications

View a list of our published and presented studies.

Read Now
Order a Test

Order Now

If you are a physician, there are a few ways to get started using FoundationOne (for solid tumors), FoundationOne Heme (for hematologic malignancies and sarcomas) and FoundationACT (for patients where tissue isn't an option) in your clinical practice.

If you are a patient, contact us for more information so you can talk with your doctor to see if FoundationOne, FoundationOne Heme or FoundationACT is right for you.